COCP - Cocrystal Pharma, Inc.

QQQ $ 445.88 $ 2.85 (0.64 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.12 $ 1.83 (0.85 %)

Previous Close

$ 1.87

Open

$ 1.79

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.72 - $ 1.79

52 Week Range

$ 1.33 - $ 3.29

Volume

14,197

Average Volume

Market Cap

19.03M

Beta (5Y Monthly)

$ -0.23

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	03-28-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-29-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-11-2022	03-31-2022	10-Q
10	03-23-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-17-2021	03-31-2021	10-Q
14	03-17-2021	12-31-2020	10-K
15	11-13-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-13-2020	03-31-2020	10-Q
18	03-27-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-09-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	04-01-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-21-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	03-31-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-16-2015	09-30-2015	10-Q
36	08-14-2015	06-30-2015	10-Q
37	05-14-2015	03-31-2015	10-Q
38	03-31-2015	12-31-2014	10-K
39	11-14-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Cocr...
05/14/2024 10:25:21

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 pr...

Cocrystal Pharma Q1 2024 EPS $(0.39) Up Fr...
05/13/2024 12:04:35

Cocrystal Pharma Completes Enrollment Of 7...
05/01/2024 12:12:55

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/10/2024 12:09:34

HC Wainwright & Co. Reiterates Buy on Cocr...
04/04/2024 10:24:22

HC Wainwright & Co. reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.

Cocrystal Pharma Q4 EPS $(0.44) Beats $(0....
03/28/2024 15:14:42

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0....

Recap: Cocrystal Pharma Q4 Earnings
03/28/2024 13:50:06

HC Wainwright & Co. Reiterates Buy on Cocr...
03/20/2024 10:47:37

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 pr...

Cocrystal Pharma Receives Pre-IND Response...
03/19/2024 12:02:19

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trialBOTHELL, Wash., March 19, 2024 (GLOBE NE...

Cocrystal Pharma Provides An Update On The...
01/04/2024 13:13:56

Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") provides an update on the clinical developm...

HC Wainwright & Co. Maintains Buy on Cocry...
01/03/2024 13:43:33

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cocrystal Pharma (NASDAQ:COCP) with a Buy and lowers the price ...

Cocrystal Pharma Received Notice From Merc...
12/21/2023 22:05:29

-8-K

Cocrystal Pharma Announces First-Patient-I...
12/06/2023 13:06:34

HC Wainwright & Co. Reiterates Buy on Cocr...
12/04/2023 11:59:15

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $12 pr...

Cocrystal Pharma Announces The Presentatio...
11/29/2023 13:14:01

Cocrystal has initiated a Phase 2a human challenge trial with oral CC-42344 in the UK in subjects infected with influenza A, an...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
11/16/2023 21:31:07

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
11/15/2023 21:31:03

Recap: Cocrystal Pharma Q3 Earnings
11/13/2023 13:35:05

Cocrystal Pharma Q3 EPS $(0.41) Beats $(0....
11/13/2023 13:14:06

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0....

Cocrystal Pharma Receives UK MHRA Authoriz...
10/31/2023 12:04:36

Cocrystal Pharma, Inc. (NASDAQ:COCP) (Cocrystal or the Company) announces receipt of authorization from the United Kingdom Medi...